Your shopping cart is currently empty

BF 227 is a candidate for an amyloid imaging probe for PET [Ki: 4.3 nM for Aβ1-42 fibrils].


| Description | BF 227 is a candidate for an amyloid imaging probe for PET [Ki: 4.3 nM for Aβ1-42 fibrils]. |
| Targets&IC50 | β-Amyloid (1–42):ki: 4.3 nM |
| In vitro | BF-227 exhibits a high binding affinity for Aβ1-42 fibrils, with a Ki value of 4.3 nM in a competitive binding assay using [125I]BF-180 (Kd value of [125I]BF-180: 10.8 nM)[1]. The AUC for BF-227 (0.994) is significantly higher than that for FDG (0.839), indicating greater sensitivity and specificity in diagnosing AD [2]. |
| Molecular Weight | 333.38 |
| Formula | C16H16FN3O2S |
| Cas No. | 845647-80-5 |
| Smiles | CN(C)c1ncc(\C=C\c2nc3ccc(OCCF)cc3o2)s1 |
| Relative Density. | 1.336 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.